SALT LAKE CITY, February 11, 2026--iVeena Delivery Systems, Inc. ("iVeena"), a clinical-stage ophthalmology company developing novel pharmacologic therapies for refractive eye diseases, today ...
Thomas Kohnen, MD, PhD, FEBO, delivered “The Short-Sighted World” as the Binkhorst Medal Lecture at the 2025 European Society of Cataract and Refractive Surgeons meeting. “Be aware that in 2050, we ...
Please provide your email address to receive an email when new articles are posted on . A machine learning model found that nitrogen dioxide and particulates increased myopia risk. Donald O. Mutti, OD ...
An increase in primary rhegmatogenous retinal detachment incidence (RRD) may be associated with a simultaneous increase in myopia among citizens residing in the Netherlands, according to study results ...
CooperVision is reporting the latest findings from its landmark MiSight® 1 day clinical study, providing new insights about myopia management and the proven efficacy of the specially designed contact ...
After a career that has included earning a PhD in molecular biology from UC Santa Barbara, co-founding a local biotechnology company, and spending seven years working in the pharmaceutical industry, ...
SEATTLE--(BUSINESS WIRE)--Kubota Vision Inc. (“Kubota Vision”), a clinical-stage ophthalmology company and wholly-owned subsidiary of Kubota Pharmaceutical Holdings Co., Ltd. (Tokyo 4596), today ...
Aug. 22 (UPI) --If it's proven to be safe and effective in large clinical trials, a metabolite of caffeine may prove valuable in slowing the progression of short-sightedness, or myopia, in children, a ...
New research from Australia indicates people with myopia are more likely to experience poorer sleep quality than people with normal vision. The study indicates that people with short-sightedness have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results